Variant report
Variant | nsv526100 |
---|---|
Chromosome Location | chr14:24225001-24234400 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAFF | chr14:24232636-24232975 | HepG2 | liver: | n/a | chr14:24232790-24232808 chr14:24232796-24232810 |
2 | MAFK | chr14:24232626-24232979 | HepG2 | liver: | n/a | chr14:24232793-24232813 chr14:24232795-24232811 chr14:24232792-24232807 chr14:24232800-24232809 chr14:24232796-24232810 |
3 | MAFK | chr14:24231850-24231939 | HepG2 | liver: | n/a | n/a |
4 | MAFK | chr14:24232691-24232947 | IMR90 | lung: | n/a | chr14:24232793-24232813 chr14:24232795-24232811 chr14:24232792-24232807 chr14:24232800-24232809 chr14:24232796-24232810 |
5 | MAFK | chr14:24232634-24232982 | HepG2 | liver: | n/a | chr14:24232793-24232813 chr14:24232795-24232811 chr14:24232792-24232807 chr14:24232800-24232809 chr14:24232796-24232810 |
6 | POLR2A | chr14:24225714-24225891 | GM12878 | blood: | n/a | n/a |
7 | REST | chr14:24227926-24228001 | GM12878 | blood: | n/a | n/a |
8 | SPI1 | chr14:24227882-24228040 | K562 | blood: | n/a | n/a |
9 | ZBTB33 | chr14:24227897-24228015 | HepG2 | liver: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000270618 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192886282 | chr14:24231900-24231901 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs76124768 | chr14:24231901-24231902 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs1958287 | chr14:24231913-24231914 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs189448260 | chr14:24232674-24232675 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs10146945 | chr14:24232676-24232677 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs386775638 | chr14:24232687-24232688 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs10135864 | chr14:24232688-24232689 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs573669709 | chr14:24232719-24232720 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs542121633 | chr14:24232823-24232824 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs373407138 | chr14:24232831-24232832 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs572207155 | chr14:24232847-24232848 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs111423886 | chr14:24232865-24232866 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs564210933 | chr14:24232873-24232874 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs533044130 | chr14:24232874-24232875 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs543471221 | chr14:24232886-24232887 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs548565768 | chr14:24232898-24232899 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs113101434 | chr14:24232900-24232901 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs7156687 | chr14:24232947-24232948 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs7157353 | chr14:24232955-24232956 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs549736015 | chr14:24232967-24232968 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs7157519 | chr14:24233026-24233027 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs528722155 | chr14:24233066-24233067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7157553 | chr14:24233067-24233068 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs571432995 | chr14:24233107-24233108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181725390 | chr14:24233136-24233137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537167690 | chr14:24233195-24233196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557001222 | chr14:24233252-24233253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567331166 | chr14:24233278-24233279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7156111 | chr14:24233306-24233307 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs145692536 | chr14:24233345-24233346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572242414 | chr14:24233422-24233423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541254988 | chr14:24233427-24233428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376723548 | chr14:24233434-24233435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186898785 | chr14:24233445-24233446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs72690319 | chr14:24233479-24233480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148540263 | chr14:24233481-24233482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563335384 | chr14:24233491-24233492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536266225 | chr14:24233516-24233517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528886594 | chr14:24233532-24233533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542247492 | chr14:24233548-24233549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538487771 | chr14:24233629-24233630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7141665 | chr14:24233661-24233662 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs76465587 | chr14:24233666-24233667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78549355 | chr14:24233709-24233710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572719192 | chr14:24233717-24233718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78264633 | chr14:24233722-24233723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550663186 | chr14:24233778-24233779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538665644 | chr14:24233797-24233798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191295428 | chr14:24233812-24233813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537630912 | chr14:24233855-24233856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Cancer | 21183584 | CNVD |
Leukoplakia | 24403051 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:24232600-24234400 | Enhancers | Liver | Liver |
2 | chr14:24234400-24235200 | Weak transcription | Liver | Liver |